5-Hydroxy Rosiglitazone-d4

Modify Date: 2024-01-03 10:21:07

5-Hydroxy Rosiglitazone-d4 Structure
5-Hydroxy Rosiglitazone-d4 structure
Common Name 5-Hydroxy Rosiglitazone-d4
CAS Number 1246817-46-8 Molecular Weight 377.45
Density N/A Boiling Point N/A
Molecular Formula C18H15D4N3O4S Melting Point N/A
MSDS N/A Flash Point N/A

 Names

Name 5-[[4-[1,1,2,2-tetradeuterio-2-[(5-hydroxypyridin-2-yl)-methylamino]ethoxy]phenyl]methyl]-1,3-thiazolidine-2,4-dione
Synonym More Synonyms

 5-Hydroxy Rosiglitazone-d4 Biological Activity

Description 5-Hydroxy Rosiglitazone-d4 是 5-Hydroxy Rosiglitazone氘代物[1]。
In Vitro Stable heavy isotopes of hydrogen, carbon, and other elements have been incorporated into drug molecules, largely as tracers for quantitation during the drug development process. Deuteration has gained attention because of its potential to affect the pharmacokinetic and metabolic profiles of drugs[1].
References

[1]. Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53(2):211-223.

 Chemical & Physical Properties

Molecular Formula C18H15D4N3O4S
Molecular Weight 377.45
Exact Mass 377.13500
PSA 120.55000
LogP 2.47240

 Synonyms

5-Hydroxy Rosiglitazone-d4
5-[[4-[2-[(5-Hydroxy-2-pyridinyl)methylamino]ethoxy-d4]phenylmethyl]-2,4-thiazolidinedione